Kevin O'Boyle

Kevin O'Boyle

Directeur/Membre du Conseil chez CARLSMED, INC.

Fortune : 528 888 $ au 31/05/2026

70 ans
Health Technology
Finance
Consumer Services

Profil

Kevin C.
O'Boyle
is currently an Independent Director at Carlsmed, Inc. since 2024, iRhythm Holdings, Inc. starting 2025, and Outset Medical, Inc. starting 2025.
He serves as Director at San Diego Hall of Champions and ChromaCode, Inc. since 2021.
He is an Advisor at HighCape Partners Management LLC and HighCape Capital Acquisition Corp.
II since 2020.
Former roles include Chairman at GenMark Diagnostics, Inc. from 2020 to 2021; Director at NeoTract, Inc. in 2017; Independent Director at ZELTIQ Aesthetics, Inc. from 2011 to 2017; Independent Non-Executive Director at Tornier NV from 2013 to 2019; Independent Director at Project Sage Oldco, Inc. from 2014 to 2023; Independent Director at Durata Therapeutics, Inc. from 2012 to 2014; Independent Non-Executive Director at Wright Medical Group NV from 2010 to 2020; Independent Director at Nevro Corp.
from 2019 to 2025; Chief Financial Officer & Senior VP-Operations at Clarient, Inc.; Chief Financial Officer at NuVasive LLC from 2003 to 2009; Chief Financial Officer & Senior Vice President at Shire Regenerative Medicine, Inc. from 2010 to 2011; Chief Financial Officer & SVP-Operations at Albert Fisher Group Plc and Albert Fisher North America, Inc.; Vice President & Controller at American Cablesystems Corp.; Advisor at HighCape Capital Acquisition Corp.; and Chief Financial & Operating Officer at Chroma Vision Medical Systems, Inc. from 1996 to 2002.
Education includes undergraduate studies at Rochester Institute of Technology.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/05/2026 3 608 ( 0,01% ) 410 951 $ 31/05/2026
04/06/2026 24 118 ( 0,14% ) 117 937 $ 31/05/2026
08/04/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Kevin O'Boyle

SociétésPosteDébut
OUTSET MEDICAL, INC. Directeur/Membre du Conseil 14/05/2025
CARLSMED, INC. Directeur/Membre du Conseil 01/09/2024
IRHYTHM HOLDINGS, INC. Directeur/Membre du Conseil 07/07/2025
Consultant / Advisor -
Directeur/Membre du Conseil 11/08/2021
Corporate Officer/Principal 01/05/2020
Directeur/Membre du Conseil 21/03/2011

Anciens postes connus de Kevin O'Boyle

SociétésPosteFin
NEVRO CORP. Directeur/Membre du Conseil 01/04/2025
PROJECT SAGE OLDCO, INC. Directeur/Membre du Conseil 15/06/2023
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Kevin O'Boyle

Formation de Kevin O'Boyle

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

52

Relations au 1er degré

24

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées24

Health Services

Health Technology

Chroma Vision Medical Systems, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Consumer Services

Health Technology

Health Technology

Health Technology

Albert Fisher North America, Inc.

Health Technology

Consumer Services

Finance

Health Technology

Technology Services

Technology Services

Finance

Finance

  1. Bourse
  2. Insiders
  3. Kevin O'Boyle
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT